Carrie Sun

3.4k total citations · 2 hit papers
20 papers, 2.8k citations indexed

About

Carrie Sun is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carrie Sun has authored 20 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carrie Sun's work include Antimicrobial Peptides and Activities (4 papers), Mitochondrial Function and Pathology (3 papers) and Peptidase Inhibition and Analysis (3 papers). Carrie Sun is often cited by papers focused on Antimicrobial Peptides and Activities (4 papers), Mitochondrial Function and Pathology (3 papers) and Peptidase Inhibition and Analysis (3 papers). Carrie Sun collaborates with scholars based in United States, China and Taiwan. Carrie Sun's co-authors include John A. Petros, Rebecca S. Arnold, Douglas C. Wallace, Fray F. Marshall, Mohammed A. Amin, Adeboye O. Osunkoya, Jendai Richards, J. David Lambeth, Qian Sun and Sean F. O’Hearn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Materials and Cancer Research.

In The Last Decade

Carrie Sun

20 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mtDNA mutations increase tumorigenicity in prostate cancer

2005 682 citations John A. Petros, Eduardo Ruiz‐Pesini et al. Proceedings of the National Academy of Sciences profile →
An Inherited Heteroplasmic Mutation in Mitochondrial Gene COI in a Patient with Prostate Cancer Alters Reactive Oxygen, Reactive Nitrogen and Proliferation

2012 621 citations Rebecca S. Arnold, Qian Sun et al. BioMed Research International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carrie Sun United States	12	1.5k	518	381	375	299	20	2.8k
Zhe Zhang China	29	1.7k 1.2×	395 0.8×	525 1.4×	211 0.6×	166 0.6×	88	3.7k
Ruifang Li China	35	2.8k 1.9×	441 0.9×	297 0.8×	357 1.0×	489 1.6×	206	4.9k
Wei Ming Australia	34	1.9k 1.3×	437 0.8×	502 1.3×	424 1.1×	194 0.6×	128	3.8k
Ying Yang China	29	1.1k 0.7×	279 0.5×	435 1.1×	518 1.4×	273 0.9×	122	2.9k
Zhigang Tu China	23	1.0k 0.7×	294 0.6×	258 0.7×	235 0.6×	229 0.8×	72	2.0k
Dinesh Kumar India	32	2.1k 1.4×	323 0.6×	274 0.7×	198 0.5×	323 1.1×	249	4.2k
Min Young Kim South Korea	35	1.8k 1.2×	442 0.9×	300 0.8×	357 1.0×	251 0.8×	167	3.7k
Xinli Liu China	35	2.3k 1.5×	385 0.7×	370 1.0×	949 2.5×	322 1.1×	169	4.3k
Bowen Li China	30	1.8k 1.2×	803 1.6×	424 1.1×	434 1.2×	185 0.6×	157	3.3k
Chunli Song China	28	1.7k 1.2×	668 1.3×	316 0.8×	247 0.7×	255 0.9×	125	4.5k

Countries citing papers authored by Carrie Sun

Since Specialization

Citations

This map shows the geographic impact of Carrie Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie Sun more than expected).

Fields of papers citing papers by Carrie Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie Sun. The network helps show where Carrie Sun may publish in the future.

Co-authorship network of co-authors of Carrie Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie Sun. A scholar is included among the top collaborators of Carrie Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie Sun. Carrie Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tapadar, Subhasish, Zhiping Ruan, Carrie Sun, et al.. (2024). A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy. ACS Pharmacology & Translational Science. 7(10). 3155–3169. 4 indexed citations

Dasari, Madhuri, Stephen C. Pelly, Jiafeng Geng, et al.. (2023). Discovery of 5′-Substituted 5-Fluoro-2′-deoxyuridine Monophosphate Analogs: A Novel Class of Thymidylate Synthase Inhibitors. ACS Pharmacology & Translational Science. 6(5). 702–709. 4 indexed citations

Li, Zhenghong, Carrie Sun, Sijia Tao, et al.. (2020). The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression. Translational Oncology. 13(4). 100751–100751. 19 indexed citations

Tapadar, Subhasish, Carrie Sun, Idris O. Raji, et al.. (2020). Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers. 12(11). 3095–3095. 10 indexed citations

Sun, Carrie, Rebecca S. Arnold, Chia‐Ling Hsieh, et al.. (2019). Discovery and mechanisms of host defense to oncogenesis: targeting the β-defensin-1 peptide as a natural tumor inhibitor. Cancer Biology & Therapy. 20(6). 774–786. 21 indexed citations

Sun, Qian, Rebecca S. Arnold, Carrie Sun, & John A. Petros. (2015). A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer. The Prostate. 75(16). 1916–1925. 26 indexed citations

Sun, Carrie, Rebecca S. Arnold, & John A. Petros. (2013). 1136 URINE HUMAN BETA DEFENSIN-1: A NATURAL BLADDER CANCER INHIBITOR. The Journal of Urology. 189(4S). 1 indexed citations

Arnold, Rebecca S., Qian Sun, Carrie Sun, et al.. (2012). An Inherited Heteroplasmic Mutation in Mitochondrial Gene COI in a Patient with Prostate Cancer Alters Reactive Oxygen, Reactive Nitrogen and Proliferation. BioMed Research International. 2013. 1–10. 621 indexed citations breakdown →

Arnold, Rebecca S., Carrie Sun, Jendai Richards, et al.. (2008). Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. The Prostate. 69(1). 1–11. 57 indexed citations

10.

Ramaraju, Harsha, et al.. (2008). ENIGMOL (2-AMINO-3,5-DIHYDROXYOCTADECANE [2S, 3S, 5S]) IS A NOVEL SPHINGOLIPID ANALOG THAT SHOWS A PROMISING EFFECT IN THE TREATMENT OF PROSTATE CANCER. The Journal of Urology. 179(4S). 46–46. 1 indexed citations

11.

Lee, Dongwon, Sirajud D. Khaja, Madhuri Dasari, et al.. (2007). In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nature Materials. 6(10). 765–769. 465 indexed citations

12.

Sun, Carrie, Rebecca S. Arnold, Amanda B. Parrish, et al.. (2006). Human β-Defensin-1, a Potential Chromosome 8p Tumor Suppressor: Control of Transcription and Induction of Apoptosis in Renal Cell Carcinoma. Cancer Research. 66(17). 8542–8549. 133 indexed citations

13.

Sun, Carrie, et al.. (2005). 623: Candidate 8ptumor Suppressor DEFB-1 Induces Apoptosis in Renal Cancer. The Journal of Urology. 173(4S). 170–170. 1 indexed citations

14.

Petros, John A., Eduardo Ruiz‐Pesini, Mohammed A. Amin, et al.. (2005). mtDNA mutations increase tumorigenicity in prostate cancer. Proceedings of the National Academy of Sciences. 102(3). 719–724. 682 indexed citations breakdown →

15.

Lim, So Dug, Carrie Sun, J. David Lambeth, et al.. (2004). Increased Nox1 and hydrogen peroxide in prostate cancer. The Prostate. 62(2). 200–207. 275 indexed citations

16.

El-Galley, Rizk, Thomas E. Keane, & Carrie Sun. (2003). Camptothecin analogues and vinblastine in the treatment of renal cell carcinoma: an in vivo study using a human orthotopic renal cancer xenograft. Urologic Oncology Seminars and Original Investigations. 21(1). 49–57. 13 indexed citations

17.

Donald, Carlton D., Carrie Sun, So Dug Lim, et al.. (2003). Cancer-Specific Loss of β-Defensin 1 in Renal and Prostatic Carcinomas. Laboratory Investigation. 83(4). 501–505. 92 indexed citations

18.

Lim, So Dug, et al.. (2003). Automated sequencing of complete mitochondrial genomes from laser-capture microdissected samples. BioTechniques. 35(3). 606–612. 5 indexed citations

19.

Arnold, Rebecca S., Jing Shi, Anne M. Whalen, et al.. (2001). Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proceedings of the National Academy of Sciences. 98(10). 5550–5555. 403 indexed citations

20.

Keane, Thomas E., Rizk El-Galley, Carrie Sun, et al.. (1998). CAMPTOTHECIN ANALOGUES/CISPLASTIN: AN EFFECTIVE TREATMENT OF ADVANCED BLADDER CANCER IN A PRECLINICAL IN VIVO MODEL SYSTEM. The Journal of Urology. 160(1). 252–256. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact